Susquehanna International »

Cue Biopharma shares owned by Susquehanna International

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Susquehanna International

Quarter filed Position value Share count Share price at filing
2026-06-30 $663k 21k 31.56

More positions owned by Susquehanna International

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Sandisk Corp (SNDK)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Vaneck Etf Trust Semiconductr Etf (SMH)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Apple (AAPL)
Meta Platforms Cl A (META)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)

View all positions for Susquehanna International

Top funds holding Cue Biopharma

Bleichroeder
Driehaus Capital Management
Vanguard Capital Management
Ikarian Capital
Polygon Management
Stempoint Capital
BlackRock
ADAR1 Capital Management
Lion Point Capital
Squadron Capital Management
Diadema Partners
Geode Capital Management
Belvedere Trading
Boothbay Fund Management
UBS Group

View all funds holding Cue Biopharma